In the recent Cannabis Business Europe 2019 conference held on 7th & 8th of November 2019 in Cologne, professionals of Medical Cannabis industry from over 15 countries made a significant added value presence, focusing on relevant market trends, production, sales and quality issues in the European Market.
During this event, Costas Vamvakas, the CEO of VK PREMIUM Consulting Group, presented the facts of why Greece is becoming “The European Production HUB for Medical Cannabis” vertical facilities.
Initially, Costas Vamvakas gave special emphasis on the expected exponential growth of European Medical Cannabis Sales within the next decade, reaching at a level of € 41 billion by 2028 (vs ~ € 3 billion in 2018).
Then he presented the solid facts making Greece the European Hub for Medicinal Cannabis production facilities.
VK PREMIUM Consulting Group based in Athens, incorporates a dedicated division with concrete expertise in Medical Cannabis licensing, business plans’ development & project management during the investment deployment.
In a nutshell, VK PREMIUM provides a real boost to deploy Medical Cannabis investment in Greece, through unique and simplified services such as:
According to Prohibition Partners European Cannabis, until 2028, the value of Greek Medical Cannabis market will reach 900 million euro.